Who knows, there might be more uptake in the US which I doubt and SleepCheck was never the primary product.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp announces FDA 510(k) submission for SleepCheckRx
Ann: ResApp announces FDA 510(k) submission for SleepCheckRx, page-23
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online